Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
Pyruvate Kinase Deficiency in Terrier Variant 1 (PKDef) is a hereditary blood disorder affecting certain dog breeds, especially terriers. This genetic condition leads to anemia due to the reduced function of the pyruvate kinase enzyme in red blood cells. Early DNA testing for PKDef helps breeders identify carriers and prevent passing the disease to puppies. Accurate PKDef DNA tests are essential for responsible breeding and maintaining healthy terrier populations. Understanding the genetic risks of PKDef ensures better care and management of affected dogs. Regular screening supports early diagnosis and improves treatment outcomes. Choose reliable PKDef DNA testing to protect your terrier’s health and future generations.
Pyruvate Kinase Deficiency in Terrier Variant 1 (PKDef) is a hereditary condition affecting certain dog breeds, particularly terriers. This genetic disorder leads to a deficiency in the pyruvate kinase enzyme, which is crucial for red blood cell energy production. Dogs with PKDef often suffer from anemia, weakness, and lethargy due to the premature breakdown of red blood cells. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions to reduce the incidence of the disease. Early diagnosis through testing is essential for managing the health and well-being of affected dogs.
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Pyruvate Kinase Deficiency (PKDef) is a genetic disorder that affects the red blood cells of dogs, leading to hemolytic anemia. This condition arises due to a mutation in the PKLR gene, which plays a crucial role in the glycolytic pathway. This pathway is responsible for the production of energy in cells, particularly in red blood cells, which rely heavily on anaerobic metabolism for energy generation.
In dogs with PKDef, the deficiency of the enzyme pyruvate kinase results in an inability to effectively produce ATP (adenosine triphosphate), the energy currency of the cell. The lack of ATP leads to the premature destruction of red blood cells, a process known as hemolysis. As a result, affected dogs may exhibit symptoms of anemia, including lethargy, pale gums, and increased heart rate.
Dogs suffering from PKDef may present with a variety of clinical signs that can vary in severity. Common symptoms include lethargy, exercise intolerance, jaundice (yellowing of the skin and eyes), dark-colored urine, and an increased respiratory rate. In some cases, affected dogs may experience episodes of collapse or weakness, particularly after physical exertion.
The diagnosis of Pyruvate Kinase Deficiency typically involves a combination of clinical evaluation and laboratory testing. A complete blood count (CBC) may reveal a reduced number of red blood cells and signs of hemolysis. Genetic testing through DNA analysis is a definitive method for diagnosing PKDef, allowing for the identification of the specific mutation in the PKLR gene.
While there is no cure for Pyruvate Kinase Deficiency, management strategies can help alleviate symptoms and improve the quality of life for affected dogs. Supportive care often includes regular veterinary check-ups, monitoring of blood parameters, and, in severe cases, blood transfusions to manage anemia. Additionally, maintaining a stress-free environment and avoiding strenuous activities can help reduce the risk of complications.
The prognosis for dogs with PKDef varies depending on the severity of the condition. Many dogs can lead relatively normal lives with appropriate management and care. However, some may experience recurrent episodes of anemia, necessitating ongoing veterinary support. Early diagnosis and intervention are crucial for enhancing the quality of life for affected dogs.
Pyruvate Kinase Deficiency in dogs is a significant genetic condition that can lead to serious health issues if not properly managed. Awareness of the signs and symptoms, along with timely genetic testing and diagnosis, can help dog owners provide the necessary care and support for affected pets. Ongoing research into this condition may provide further insights into treatment options and potential advancements in management strategies.
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
This DNA test detects the mutation associated with Pyruvate Kinase Deficiency In Terrier Variant 1 (PKDef-T1) in order to identify clear, carrier, or at-risk animals.
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
This test analyses the mutation PKLR c.1333_1338dup.
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
Skelly B J, Wallace M, Rajpurohit Y R, Wang P, Giger U. Identification of a 6 base pair insertion in West Highland White Terriers with erythrocyte pyruvate kinase deficiency. Am J Vet Res. 1999 Sep;60(9):1169-72.
Bo privasidat, bo eskoho
Nos ta usa kuki esensial pa manehá e wèpsait. Kuki opshonal (manera dunadónan di kontenido inkorporá) ta desabilitá pa default i ta wòrdu aktivá solamente si bo ta di akuerdo. Bo por kambia bo eskoho na kualke momento usando e boton “Cookies”.
Ta nesesario pa karakterístikanan prinsipal i seguridat. Semper aktivá.
Ta mehorá funshonnan manera sparmentu di preferensia òf inkorporashon no-propaganda.
Yuda nos komprondé e uso di e wèpsait. Deshabilitá pa default.
Propaganda/tracking atraves di wèpsaitnan (algun video/mapa ta inkorporá). Deshabilitá pa default.